These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32925621)

  • 1. Mifepristone Combination Therapy Compared With Misoprostol Monotherapy for the Management of Miscarriage: A Cost-Effectiveness Analysis.
    Berkley HH; Greene HL; Wittenberger MD
    Obstet Gynecol; 2020 Oct; 136(4):774-781. PubMed ID: 32925621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage: an economic evaluation based on the MifeMiso trial.
    Okeke Ogwulu CB; Williams EV; Chu JJ; Devall AJ; Beeson LE; Hardy P; Cheed V; Yongzhong S; Jones LL; La Fontaine Papadopoulos JH; Bender-Atik R; Brewin J; Hinshaw K; Choudhary M; Ahmed A; Naftalin J; Nunes N; Oliver A; Izzat F; Bhatia K; Hassan I; Jeve Y; Hamilton J; Debs S; Bottomley C; Ross J; Watkins L; Underwood M; Cheong Y; Kumar CS; Gupta P; Small R; Pringle S; Hodge FS; Shahid A; Horne AW; Quenby S; Gallos ID; Coomarasamy A; Roberts TE
    BJOG; 2021 Aug; 128(9):1534-1545. PubMed ID: 33969614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical methods for first trimester abortion.
    Kulier R; Gülmezoglu AM; Hofmeyr GJ; Cheng LN; Campana A
    Cochrane Database Syst Rev; 2004; (2):CD002855. PubMed ID: 15106180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical methods for first trimester abortion.
    Kulier R; Gülmezoglu AM; Hofmeyr GJ; Cheng LN; Campana A
    Cochrane Database Syst Rev; 2004; (1):CD002855. PubMed ID: 14973995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of a randomized controlled trial comparing mifepristone and misoprostol with misoprostol alone in the treatment of early pregnancy loss.
    Hamel CC; Snijders MPLM; Coppus SFPJ; Vandenbussche FPHA; Braat DDM; Adang EMM
    PLoS One; 2022; 17(2):e0262894. PubMed ID: 35139105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical abortion with mifepristone and vaginal misoprostol between 64 and 70 days' gestation.
    Hsia JK; Lohr PA; Taylor J; Creinin MD
    Contraception; 2019 Sep; 100(3):178-181. PubMed ID: 31102629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing and indication for curettage after medical abortion in early pregnant women with prior uterine incision.
    Wang G; Li D; Manconi F; Dong B; Zhang Y; Sun B
    Contraception; 2010 Jan; 81(1):62-6. PubMed ID: 20004275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The costs and cost effectiveness of providing second-trimester medical and surgical safe abortion services in Western Cape Province, South Africa.
    Lince-Deroche N; Constant D; Harries J; Kluge J; Blanchard K; Sinanovic E; Grossman D
    PLoS One; 2018; 13(6):e0197485. PubMed ID: 29953434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical Preparation Before Dilation and Evacuation Using Adjunctive Misoprostol or Mifepristone Compared With Overnight Osmotic Dilators Alone: A Randomized Controlled Trial.
    Goldberg AB; Fortin JA; Drey EA; Dean G; Lichtenberg ES; Bednarek PH; Chen BA; Dutton C; McKetta S; Maurer R; Winikoff B; Fitzmaurice GM
    Obstet Gynecol; 2015 Sep; 126(3):599-609. PubMed ID: 26196084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of uterine evacuation following early medical abortion with mifepristone and misoprostol.
    Reeves MF; Monmaney JA; Creinin MD
    Contraception; 2016 Feb; 93(2):119-25. PubMed ID: 26285178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of Mifepristone Pretreatment for the Medical Management of Nonviable Early Pregnancy: Secondary Analysis of a Randomized Clinical Trial.
    Nagendra D; Koelper N; Loza-Avalos SE; Sonalkar S; Chen M; Atrio J; Schreiber CA; Harvie HS
    JAMA Netw Open; 2020 Mar; 3(3):e201594. PubMed ID: 32215633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal vs. sublingual misoprostol with mifepristone for cervical priming in second-trimester abortion by dilation and evacuation: a randomized clinical trial.
    Carbonell JL; Gallego FG; Llorente MP; Bermudez SB; Sala ES; González LV; Texido CS
    Contraception; 2007 Mar; 75(3):230-7. PubMed ID: 17303495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical versus surgical abortion methods for pregnancy in China: a cost-minimization analysis.
    Xia W; She S; Lam TH
    Gynecol Obstet Invest; 2011; 72(4):257-63. PubMed ID: 21997301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mifepristone and misoprostol versus dilation and evacuation for midtrimester abortion: a pilot randomised controlled trial.
    Grimes DA; Smith MS; Witham AD
    BJOG; 2004 Feb; 111(2):148-53. PubMed ID: 14723752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing two early medical abortion regimens: mifepristone+misoprostol vs. misoprostol alone.
    Ngoc NT; Blum J; Raghavan S; Nga NT; Dabash R; Diop A; Winikoff B
    Contraception; 2011 May; 83(5):410-7. PubMed ID: 21477682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misoprostol versus manual vacuum aspiration for treatment of first-trimester incomplete miscarriage in a low-resource setting: A randomized controlled trial.
    Nwafor JI; Agwu UM; Egbuji CC; Ekwedigwe KC
    Niger J Clin Pract; 2020 May; 23(5):638-646. PubMed ID: 32367870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical versus expectant management in women with an incomplete evacuation of the uterus after treatment with misoprostol for miscarriage: the MisoREST trial.
    Verschoor MA; Lemmers M; Bossuyt PM; Graziosi GC; Hajenius PJ; Hendriks DJ; van Hooff MA; van Meurs HS; Opmeer BC; van Tulder MW; Bouwma L; Catshoek R; Geomini P; Klinkert ER; Langenveld J; Nieboer TE; van der Ploeg JM; Radder CM; Spinder T; van der Voet LF; Mol BW; Huirne JA; Ankum WM
    BMC Pregnancy Childbirth; 2013 May; 13():102. PubMed ID: 23638956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of curettage vs. expectant management in women with an incomplete evacuation after misoprostol treatment for first-trimester miscarriage: a randomized controlled trial and cohort study.
    Lemmers M; Verschoor MAC; Bossuyt PM; Huirne JAF; Spinder T; Nieboer TE; Bongers MY; Janssen IAH; Van Hooff MHA; Mol BWJ; Ankum WM; Bosmans JE;
    Acta Obstet Gynecol Scand; 2018 Mar; 97(3):294-300. PubMed ID: 29266169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mifepristone With Buccal Misoprostol for Medical Abortion: A Systematic Review.
    Chen MJ; Creinin MD
    Obstet Gynecol; 2015 Jul; 126(1):12-21. PubMed ID: 26241251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flexible mifepristone and misoprostol administration interval for first-trimester medical termination.
    Wedisinghe L; Elsandabesee D
    Contraception; 2010 Apr; 81(4):269-74. PubMed ID: 20227541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.